The impact of coding germline variants on contralateral breast cancer risk and survival

Evidence linking coding germline variants in breast cancer (BC)-susceptibility genes other than BRCA1, BRCA2, and CHEK2 with contralateral breast cancer (CBC) risk and breast cancer-specific survival (BCSS) is scarce. The aim of this study was to assess the association of protein-truncating variants...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Morra, Anna (VerfasserIn) , Chang-Claude, Jenny (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2 March 2023
In: The American journal of human genetics
Year: 2023, Jahrgang: 110, Heft: 3, Pages: 475-486
ISSN:1537-6605
DOI:10.1016/j.ajhg.2023.02.003
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.ajhg.2023.02.003
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0002929723000472
Volltext
Verfasserangaben:Anna Morra, Nasim Mavaddat, Taru A. Muranen, Thomas U. Ahearn, Jamie Allen, Irene L. Andrulis, Päivi Auvinen, Heiko Becher, Sabine Behrens, Carl Blomqvist, Stig E. Bojesen, Manjeet K. Bolla, Hiltrud Brauch, Nicola J. Camp, Sara Carvalho, Jose E. Castelao, Melissa H. Cessna, Jenny Chang-Claude, Georgia Chenevix-Trench,NBCS Collaborators, Kamila Czene, Brennan Decker, Joe Dennis, Thilo Dörk, Leila Dorling, Alison M. Dunning, Arif B. Ekici, Mikael Eriksson, D. Gareth Evans, Peter A. Fasching, Jonine D. Figueroa, Henrik Flyger,Manuela Gago-Dominguez, Montserrat García-Closas, Willemina R.R. Geurts-Giele, Graham G. Giles, Pascal Guénel, Melanie Gündert, Eric Hahnen, Per Hall, Ute Hamann, Patricia A. Harrington, Wei He, Päivi Heikkilä, Maartje J. Hooning, Reiner Hoppe, Anthony Howell, Keith Humphreys, kConFab Investigators, Anna Jakubowska, Audrey Y. Jung, Renske Keeman, Vessela N. Kristensen, Jan Lubinski, Arto Mannermaa, Mehdi Manoochehri, Siranoush Manoukian, Sara Margolin, Dimitrios Mavroudis, Roger L. Milne, Anna Marie Mulligan, William G. Newman, Tjoung-Won Park-Simon, Paolo Peterlongo, Paul D.P. Pharoah, Valerie Rhenius, Emmanouil Saloustros, Elinor J. Sawyer, Rita K. Schmutzler, Mitul Shah, Amanda B. Spurdle, Ian Tomlinson, Thérèse Truong, Elke M. van Veen, Maaike P.G. Vreeswijk, Qin Wang, Camilla Wendt, Xiaohong R. Yang, Heli Nevanlinna, Peter Devilee, Douglas F. Easton, and Marjanka K. Schmidt

MARC

LEADER 00000caa a2200000 c 4500
001 1850428263
003 DE-627
005 20230706203243.0
007 cr uuu---uuuuu
008 230616s2023 xx |||||o 00| ||eng c
024 7 |a 10.1016/j.ajhg.2023.02.003  |2 doi 
035 |a (DE-627)1850428263 
035 |a (DE-599)KXP1850428263 
035 |a (OCoLC)1389529604 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Morra, Anna  |e VerfasserIn  |0 (DE-588)1237128331  |0 (DE-627)1763035298  |4 aut 
245 1 4 |a The impact of coding germline variants on contralateral breast cancer risk and survival  |c Anna Morra, Nasim Mavaddat, Taru A. Muranen, Thomas U. Ahearn, Jamie Allen, Irene L. Andrulis, Päivi Auvinen, Heiko Becher, Sabine Behrens, Carl Blomqvist, Stig E. Bojesen, Manjeet K. Bolla, Hiltrud Brauch, Nicola J. Camp, Sara Carvalho, Jose E. Castelao, Melissa H. Cessna, Jenny Chang-Claude, Georgia Chenevix-Trench,NBCS Collaborators, Kamila Czene, Brennan Decker, Joe Dennis, Thilo Dörk, Leila Dorling, Alison M. Dunning, Arif B. Ekici, Mikael Eriksson, D. Gareth Evans, Peter A. Fasching, Jonine D. Figueroa, Henrik Flyger,Manuela Gago-Dominguez, Montserrat García-Closas, Willemina R.R. Geurts-Giele, Graham G. Giles, Pascal Guénel, Melanie Gündert, Eric Hahnen, Per Hall, Ute Hamann, Patricia A. Harrington, Wei He, Päivi Heikkilä, Maartje J. Hooning, Reiner Hoppe, Anthony Howell, Keith Humphreys, kConFab Investigators, Anna Jakubowska, Audrey Y. Jung, Renske Keeman, Vessela N. Kristensen, Jan Lubinski, Arto Mannermaa, Mehdi Manoochehri, Siranoush Manoukian, Sara Margolin, Dimitrios Mavroudis, Roger L. Milne, Anna Marie Mulligan, William G. Newman, Tjoung-Won Park-Simon, Paolo Peterlongo, Paul D.P. Pharoah, Valerie Rhenius, Emmanouil Saloustros, Elinor J. Sawyer, Rita K. Schmutzler, Mitul Shah, Amanda B. Spurdle, Ian Tomlinson, Thérèse Truong, Elke M. van Veen, Maaike P.G. Vreeswijk, Qin Wang, Camilla Wendt, Xiaohong R. Yang, Heli Nevanlinna, Peter Devilee, Douglas F. Easton, and Marjanka K. Schmidt 
264 1 |c 2 March 2023 
300 |a 13 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online verfügbar 23. Februar 2023, Artikelversion 2. März 2023 
500 |a Gesehen am 16.06.2023 
520 |a Evidence linking coding germline variants in breast cancer (BC)-susceptibility genes other than BRCA1, BRCA2, and CHEK2 with contralateral breast cancer (CBC) risk and breast cancer-specific survival (BCSS) is scarce. The aim of this study was to assess the association of protein-truncating variants (PTVs) and rare missense variants (MSVs) in nine known (ATM, BARD1, BRCA1, BRCA2, CHEK2, PALB2, RAD51C, RAD51D, and TP53) and 25 suspected BC-susceptibility genes with CBC risk and BCSS. Hazard ratios (HRs) and 95% confidence intervals (CIs) were estimated with Cox regression models. Analyses included 34,401 women of European ancestry diagnosed with BC, including 676 CBCs and 3,449 BC deaths; the median follow-up was 10.9 years. Subtype analyses were based on estrogen receptor (ER) status of the first BC. Combined PTVs and pathogenic/likely pathogenic MSVs in BRCA1, BRCA2, and TP53 and PTVs in CHEK2 and PALB2 were associated with increased CBC risk [HRs (95% CIs): 2.88 (1.70-4.87), 2.31 (1.39-3.85), 8.29 (2.53-27.21), 2.25 (1.55-3.27), and 2.67 (1.33-5.35), respectively]. The strongest evidence of association with BCSS was for PTVs and pathogenic/likely pathogenic MSVs in BRCA2 (ER-positive BC) and TP53 and PTVs in CHEK2 [HRs (95% CIs): 1.53 (1.13-2.07), 2.08 (0.95-4.57), and 1.39 (1.13-1.72), respectively, after adjusting for tumor characteristics and treatment]. HRs were essentially unchanged when censoring for CBC, suggesting that these associations are not completely explained by increased CBC risk, tumor characteristics, or treatment. There was limited evidence of associations of PTVs and/or rare MSVs with CBC risk or BCSS for the 25 suspected BC genes. The CBC findings are relevant to treatment decisions, follow-up, and screening after BC diagnosis. 
650 4 |a breast cancer susceptibility genes 
650 4 |a coding germline variants 
650 4 |a contralateral breast cancer risk 
650 4 |a survival 
700 1 |a Chang-Claude, Jenny  |e VerfasserIn  |0 (DE-588)1049304993  |0 (DE-627)781626188  |0 (DE-576)168344475  |4 aut 
773 0 8 |i Enthalten in  |t The American journal of human genetics  |d New York, NY [u.a.] : Cell Press, 1949  |g 110(2023), 3 vom: März, Seite 475-486  |w (DE-627)269019014  |w (DE-600)1473813-2  |w (DE-576)077662636  |x 1537-6605  |7 nnas  |a The impact of coding germline variants on contralateral breast cancer risk and survival 
773 1 8 |g volume:110  |g year:2023  |g number:3  |g month:03  |g pages:475-486  |g extent:13  |a The impact of coding germline variants on contralateral breast cancer risk and survival 
856 4 0 |u https://doi.org/10.1016/j.ajhg.2023.02.003  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.sciencedirect.com/science/article/pii/S0002929723000472  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230616 
993 |a Article 
994 |a 2023 
998 |g 1049304993  |a Chang-Claude, Jenny  |m 1049304993:Chang-Claude, Jenny  |d 50000  |e 50000PC1049304993  |k 0/50000/  |p 18 
999 |a KXP-PPN1850428263  |e 4339753009 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"recId":"269019014","name":{"displayForm":["American Society of Human Genetics"]},"id":{"zdb":["1473813-2"],"issn":["1537-6605"],"eki":["269019014"]},"origin":[{"dateIssuedDisp":"1949-","publisher":"Cell Press ; Elsevier ; Univ. of Chicago Press","dateIssuedKey":"1949","publisherPlace":"New York, NY [u.a.] ; New York, NY ; Chicago, Ill."}],"note":["Gesehen am 28.05.2020"],"pubHistory":["1.1949 -"],"title":[{"title_sort":"American journal of human genetics","title":"The American journal of human genetics"}],"disp":"The impact of coding germline variants on contralateral breast cancer risk and survivalThe American journal of human genetics","type":{"bibl":"periodical","media":"Online-Ressource"},"language":["eng"],"part":{"extent":"13","volume":"110","text":"110(2023), 3 vom: März, Seite 475-486","issue":"3","pages":"475-486","year":"2023"},"corporate":[{"role":"isb","display":"American Society of Human Genetics"}]}],"recId":"1850428263","physDesc":[{"extent":"13 S."}],"name":{"displayForm":["Anna Morra, Nasim Mavaddat, Taru A. Muranen, Thomas U. Ahearn, Jamie Allen, Irene L. Andrulis, Päivi Auvinen, Heiko Becher, Sabine Behrens, Carl Blomqvist, Stig E. Bojesen, Manjeet K. Bolla, Hiltrud Brauch, Nicola J. Camp, Sara Carvalho, Jose E. Castelao, Melissa H. Cessna, Jenny Chang-Claude, Georgia Chenevix-Trench,NBCS Collaborators, Kamila Czene, Brennan Decker, Joe Dennis, Thilo Dörk, Leila Dorling, Alison M. Dunning, Arif B. Ekici, Mikael Eriksson, D. Gareth Evans, Peter A. Fasching, Jonine D. Figueroa, Henrik Flyger,Manuela Gago-Dominguez, Montserrat García-Closas, Willemina R.R. Geurts-Giele, Graham G. Giles, Pascal Guénel, Melanie Gündert, Eric Hahnen, Per Hall, Ute Hamann, Patricia A. Harrington, Wei He, Päivi Heikkilä, Maartje J. Hooning, Reiner Hoppe, Anthony Howell, Keith Humphreys, kConFab Investigators, Anna Jakubowska, Audrey Y. Jung, Renske Keeman, Vessela N. Kristensen, Jan Lubinski, Arto Mannermaa, Mehdi Manoochehri, Siranoush Manoukian, Sara Margolin, Dimitrios Mavroudis, Roger L. Milne, Anna Marie Mulligan, William G. Newman, Tjoung-Won Park-Simon, Paolo Peterlongo, Paul D.P. Pharoah, Valerie Rhenius, Emmanouil Saloustros, Elinor J. Sawyer, Rita K. Schmutzler, Mitul Shah, Amanda B. Spurdle, Ian Tomlinson, Thérèse Truong, Elke M. van Veen, Maaike P.G. Vreeswijk, Qin Wang, Camilla Wendt, Xiaohong R. Yang, Heli Nevanlinna, Peter Devilee, Douglas F. Easton, and Marjanka K. Schmidt"]},"id":{"doi":["10.1016/j.ajhg.2023.02.003"],"eki":["1850428263"]},"title":[{"title_sort":"impact of coding germline variants on contralateral breast cancer risk and survival","title":"The impact of coding germline variants on contralateral breast cancer risk and survival"}],"origin":[{"dateIssuedDisp":"2 March 2023","dateIssuedKey":"2023"}],"note":["Online verfügbar 23. Februar 2023, Artikelversion 2. März 2023","Gesehen am 16.06.2023"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"person":[{"role":"aut","given":"Anna","display":"Morra, Anna","family":"Morra"},{"display":"Chang-Claude, Jenny","family":"Chang-Claude","given":"Jenny","role":"aut"}]} 
SRT |a MORRAANNACIMPACTOFCO2202